Compare PDEX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDEX | TKNO |
|---|---|---|
| Founded | 1978 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.1M | 138.1M |
| IPO Year | 1995 | 2021 |
| Metric | PDEX | TKNO |
|---|---|---|
| Price | $50.98 | $3.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $56.00 | N/A |
| AVG Volume (30 Days) | 17.8K | ★ 110.0K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 345.00 | 43.86 |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $66,593,000.00 | $40,520,000.00 |
| Revenue This Year | $7.22 | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $24.52 | ★ N/A |
| Revenue Growth | ★ 23.68 | 7.35 |
| 52 Week Low | $23.52 | $1.91 |
| 52 Week High | $70.25 | $7.48 |
| Indicator | PDEX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 49.01 | 58.34 |
| Support Level | $37.15 | $3.01 |
| Resistance Level | $51.74 | $3.25 |
| Average True Range (ATR) | 2.21 | 0.25 |
| MACD | -0.39 | 0.02 |
| Stochastic Oscillator | 20.79 | 89.29 |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.